Tue, 23 January 2018
In this episode of AI in industry, Innoplexus CEO Gunjan Bhardwaj explores how pharma giants are working to overcome two critical challenges with AI: Data, and talent.
Pharmaceutical data is challenging because the same term (say "EGFR") might be referred to as a "protein", a "biomarker", or a "target". Gunjan explores how this kind of relevance and context for data - and how pharma companies may need to hire the talent issues involved with making life sciences and computer sciences teams work together productively.
See the full interview article online at: